A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose Scientific literature GHDx Entry last modified on: Mar 14, 2022
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study Scientific literature GHDx Entry last modified on: May 12, 2022
Covid-19 Vaccination Strategy In Spain Estrategia De Vacunación Covid-19 En Espana Epi surveillance GHDx Entry last modified on: Aug 10, 2021
United States - COVID-19 Reported Patient Impact and Hospital Capacity by Facility COVID-19 Reported Patient Impact and Hospital Capacity by Facility Epi surveillance: Health facility GHDx Entry last modified on: May 12, 2022
United States - COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series Epi surveillance: Health facility - Subnationally representative GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
United States - COVID-19 Reported Patient Impact and Hospital Capacity by State Timeseries Epi surveillance: Health facility - Subnationally representative GHDx Entry last modified on: May 12, 2022
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021 COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021) Epi surveillance: Cross-sectional - Individual GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
33.98% of Tripura has COVID-19 antibody in them, shows sero survey Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Australia Household Impacts of Covid-19 Survey November 2020 Insights into the prevalence and nature of impacts from COVID-19 on households in Australia - Round 4 Survey GHDx Entry last modified on: Aug 10, 2021
Canada - British Columbia COVID-19 Situation Report Weekly Bulletin British Columbia (BC) COVID-19 Situation Report Epi surveillance GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: May 12, 2022
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020 Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER) Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
India - Haryana Covid-19 Sero Survey Round 2, October 2020 Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round) Survey: Cross-sectional - Epi surveillance - Urban-rural representative GHDx Entry last modified on: May 12, 2022
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1 ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION Survey GHDx Entry last modified on: May 12, 2022
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4 Survey GHDx Entry last modified on: Jun 22, 2022
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October Epi surveillance GHDx Entry last modified on: May 12, 2022
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020 RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020 Epi surveillance: Subnationally representative GHDx Entry last modified on: Aug 6, 2021
Spain - Catalonia COVID-19 Weekly Confirmed Cases and Deaths Incidència setmanal de la covid-19 Epi surveillance GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Feb 10, 2022
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Brazil - Rio Grande do Sul COVID-19 Testing Results Projecto Testar RS Epi surveillance GHDx Entry last modified on: May 12, 2022
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey Survey: Cross-sectional - Epi surveillance - Individual GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19 Survey: Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: May 12, 2022
Sweden - Uppsala First Wave COVID-19 ICU Patient Cohort Admitted Mar-Aug 2020, 3-6 Month Follow-up Sept-Nov 2020 Survey: Health facility - Individual - Interview - Longitudinal GHDx Entry last modified on: Jan 27, 2022
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest Survey: Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: May 12, 2022
India - Jharkhand Regional Outreach Bureau Twitter Communications and COVID-19 Updates Epi surveillance GHDx Entry last modified on: Feb 10, 2022
Mexico - Yucatán Under-5 Endline Household Survey 2020 Survey: Cross-sectional - Household - Individual - Interview GHDx Entry last modified on: Mar 12, 2022
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020 Epi surveillance GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Feb 10, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Feb 10, 2022
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020 COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020 Epi surveillance GHDx Entry last modified on: May 12, 2022
About 10 million people have been infected with the Corona virus in Afghanistan حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند Survey GHDx Entry last modified on: Jul 13, 2021
Press Briefing: Sero Survey Delhi Survey: Cross-sectional - Urban only GHDx Entry last modified on: Feb 10, 2022
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020 HAARVI Survey: Health facility - Longitudinal - Outpatient GHDx Entry last modified on: Jan 12, 2022
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey Survey: Urban only GHDx Entry last modified on: Apr 8, 2022
India - Haryana Covid -19 Sero Survey Round 1, August 2020 Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in Haryana, India: a Population-Based Cross Sectional Study Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint Scientific literature: Epi surveillance GHDx Entry last modified on: Apr 8, 2022
29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey Survey GHDx Entry last modified on: Feb 10, 2022
Assam's Sero-survey found 23.7 per cent Seroprevalence in the State Survey: Epi surveillance GHDx Entry last modified on: Aug 6, 2021